Figure 3. The diagnostic powers of the e antigen positive liver fibrosis (EPLF) score, FIB-4, and APRI for predicting liver fibrosis in validation set.

(A) ROC plot for EPLF score, Fib-4, and APRI in differentiating significant fibrosis(METAVIR≥F2) from mild fibrosis(MATAIRE F0-F1) in the validation set. EPLF score had an AUROC of 0.83, as comparing, FIB-4 and APRI had an AUROC of 0.75 and 0.73 respectively. (B) ROC plot for EPLF score, Fib-4, and APRI in differentiating advanced fibrosis(METARIR≥F3) from mild to moderate fibrosis(METAVIR F0-F2) in the validation set. EPLF score had an AUROC of 0.86, as comparing, FIB-4 and APRI had an AUROC of 0.77 and 0.73 respectively. (C) ROC plot for EPLF score, Fib-4, and APRI in diagnosis of cirrhosis(METAVIR, F4) in